Cargando…
A Population-Based Analysis of BRCA1/2 Genes and Associated Breast and Ovarian Cancer Risk in Korean Patients: A Multicenter Cohort Study
SIMPLE SUMMARY: Although it has been suggested that cancer risk and genetic variation vary by population, there is still a lack of research on non-European populations. In this study, we applied Korean patients as a model to find out the way to conduct BRCA1/2-related clinical studies in non-Europea...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125125/ https://www.ncbi.nlm.nih.gov/pubmed/34063308 http://dx.doi.org/10.3390/cancers13092192 |
_version_ | 1783693408565460992 |
---|---|
author | Park, Kyung-Sun Lee, Woochang Seong, Moon-Woo Kong, Sun-Young Lee, Kyung-A Ha, Jung-Sook Cho, Eun-Hae Han, Sung-Hee Park, Inho Kim, Jong-Won |
author_facet | Park, Kyung-Sun Lee, Woochang Seong, Moon-Woo Kong, Sun-Young Lee, Kyung-A Ha, Jung-Sook Cho, Eun-Hae Han, Sung-Hee Park, Inho Kim, Jong-Won |
author_sort | Park, Kyung-Sun |
collection | PubMed |
description | SIMPLE SUMMARY: Although it has been suggested that cancer risk and genetic variation vary by population, there is still a lack of research on non-European populations. In this study, we applied Korean patients as a model to find out the way to conduct BRCA1/2-related clinical studies in non-European populations who do not have as much clinical data as Europeans. The BRCA1/2 variants were classified following the 2015 ACMG standards/guidelines and using a multifactorial probability-based approach. To estimate the additional sample numbers needed to resolve BRCA1/2 unclassified status, we applied a simulation analysis considering population-specific clinical characteristics. In addition, we estimated the risks of breast or ovarian cancer for BRCA1/2 carriers by mutation regions. Data from this study reveal that BRCA1/2 variants in the non-European population are highly specific; therefore, population-specific study is essential for clinical application of treatment or prevention for breast or ovarian cancer. ABSTRACT: In this study, we performed a comprehensive analysis of BRCA1/2 variants and associated cancer risk in Korean patients considering two aspects: variants of uncertain significance (VUS) and pathogenic or likely pathogenic variants (PLPVs) in BRCA1 and BRCA2. This study included 5433 Korean participants who were tested for BRCA1/2 genes. The BRCA1/2 variants were classified following the standards/guidelines for interpretation of genetic variants and using a multifactorial probability-based approach. In Korea, 15.8% of participants had BRCA1 or BRCA2 PLPVs. To estimate the additional sample numbers needed to resolve unclassified status, we applied a simulation analysis. The simulation study for VUS showed that the smaller the number of samples, the more the posterior probability was affected by the prior probability; in addition, more samples for BRCA2 VUS than those of BRCA1 VUS were required to resolve the unclassified status, and the presence of clinical information associated with their VUS was an important factor. The cumulative lifetime breast cancer risk was 59.1% (95% CI: 44.1–73.6%) for BRCA1 and 58.3% (95% CI: 43.2–73.0%) for BRCA2 carriers. The cumulative lifetime ovarian cancer risk was estimated to be 36.9% (95% CI: 23.4–53.9%) for BRCA1 and 14.9% (95% CI: 7.4–28.5%) for BRCA2 carriers. |
format | Online Article Text |
id | pubmed-8125125 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81251252021-05-17 A Population-Based Analysis of BRCA1/2 Genes and Associated Breast and Ovarian Cancer Risk in Korean Patients: A Multicenter Cohort Study Park, Kyung-Sun Lee, Woochang Seong, Moon-Woo Kong, Sun-Young Lee, Kyung-A Ha, Jung-Sook Cho, Eun-Hae Han, Sung-Hee Park, Inho Kim, Jong-Won Cancers (Basel) Article SIMPLE SUMMARY: Although it has been suggested that cancer risk and genetic variation vary by population, there is still a lack of research on non-European populations. In this study, we applied Korean patients as a model to find out the way to conduct BRCA1/2-related clinical studies in non-European populations who do not have as much clinical data as Europeans. The BRCA1/2 variants were classified following the 2015 ACMG standards/guidelines and using a multifactorial probability-based approach. To estimate the additional sample numbers needed to resolve BRCA1/2 unclassified status, we applied a simulation analysis considering population-specific clinical characteristics. In addition, we estimated the risks of breast or ovarian cancer for BRCA1/2 carriers by mutation regions. Data from this study reveal that BRCA1/2 variants in the non-European population are highly specific; therefore, population-specific study is essential for clinical application of treatment or prevention for breast or ovarian cancer. ABSTRACT: In this study, we performed a comprehensive analysis of BRCA1/2 variants and associated cancer risk in Korean patients considering two aspects: variants of uncertain significance (VUS) and pathogenic or likely pathogenic variants (PLPVs) in BRCA1 and BRCA2. This study included 5433 Korean participants who were tested for BRCA1/2 genes. The BRCA1/2 variants were classified following the standards/guidelines for interpretation of genetic variants and using a multifactorial probability-based approach. In Korea, 15.8% of participants had BRCA1 or BRCA2 PLPVs. To estimate the additional sample numbers needed to resolve unclassified status, we applied a simulation analysis. The simulation study for VUS showed that the smaller the number of samples, the more the posterior probability was affected by the prior probability; in addition, more samples for BRCA2 VUS than those of BRCA1 VUS were required to resolve the unclassified status, and the presence of clinical information associated with their VUS was an important factor. The cumulative lifetime breast cancer risk was 59.1% (95% CI: 44.1–73.6%) for BRCA1 and 58.3% (95% CI: 43.2–73.0%) for BRCA2 carriers. The cumulative lifetime ovarian cancer risk was estimated to be 36.9% (95% CI: 23.4–53.9%) for BRCA1 and 14.9% (95% CI: 7.4–28.5%) for BRCA2 carriers. MDPI 2021-05-02 /pmc/articles/PMC8125125/ /pubmed/34063308 http://dx.doi.org/10.3390/cancers13092192 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Park, Kyung-Sun Lee, Woochang Seong, Moon-Woo Kong, Sun-Young Lee, Kyung-A Ha, Jung-Sook Cho, Eun-Hae Han, Sung-Hee Park, Inho Kim, Jong-Won A Population-Based Analysis of BRCA1/2 Genes and Associated Breast and Ovarian Cancer Risk in Korean Patients: A Multicenter Cohort Study |
title | A Population-Based Analysis of BRCA1/2 Genes and Associated Breast and Ovarian Cancer Risk in Korean Patients: A Multicenter Cohort Study |
title_full | A Population-Based Analysis of BRCA1/2 Genes and Associated Breast and Ovarian Cancer Risk in Korean Patients: A Multicenter Cohort Study |
title_fullStr | A Population-Based Analysis of BRCA1/2 Genes and Associated Breast and Ovarian Cancer Risk in Korean Patients: A Multicenter Cohort Study |
title_full_unstemmed | A Population-Based Analysis of BRCA1/2 Genes and Associated Breast and Ovarian Cancer Risk in Korean Patients: A Multicenter Cohort Study |
title_short | A Population-Based Analysis of BRCA1/2 Genes and Associated Breast and Ovarian Cancer Risk in Korean Patients: A Multicenter Cohort Study |
title_sort | population-based analysis of brca1/2 genes and associated breast and ovarian cancer risk in korean patients: a multicenter cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125125/ https://www.ncbi.nlm.nih.gov/pubmed/34063308 http://dx.doi.org/10.3390/cancers13092192 |
work_keys_str_mv | AT parkkyungsun apopulationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT leewoochang apopulationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT seongmoonwoo apopulationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT kongsunyoung apopulationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT leekyunga apopulationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT hajungsook apopulationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT choeunhae apopulationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT hansunghee apopulationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT parkinho apopulationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT kimjongwon apopulationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT parkkyungsun populationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT leewoochang populationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT seongmoonwoo populationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT kongsunyoung populationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT leekyunga populationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT hajungsook populationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT choeunhae populationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT hansunghee populationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT parkinho populationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy AT kimjongwon populationbasedanalysisofbrca12genesandassociatedbreastandovariancancerriskinkoreanpatientsamulticentercohortstudy |